Probiotics in Mild Alzheimer's Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The main objective is to investigate whether administration of probiotics to patients with mild Alzheimer\'s Disease (AD) reduces neuroinflammation, improves cognitive function and modifies neurophysiological measures, compared to a patient group that receives placebo (no active probiotics).
Epistemonikos ID: 189facc7024073aa307474c183b97447c3703760
First added on: May 15, 2024